cyclophosphamide cell therapy (PharmaCyte/Austrianova)

N/A

Report date: 2025/01/26 18:21:48

Base Information

Drug Namecyclophosphamide cell therapy (PharmaCyte/Austrianova)
Drug Alias Namecyclophosphamide cell therapy (Nuvilex/Austrianova)
ClassificationCell and gene therapy > Cell therapySmall molecules > Prodrug > Directed prodrug therapy
Mechanisms of ActionCytochrome P450 modulators
TargetsCytochrome P450
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPharmacyte Biotech
China Registration ClassN/A

Develop Information

Active CompaniesPharmacyte BiotechSg Austria
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A